(Q37650273)

21 August 2017

1 reference

title

Is lithium in a class of its own? A brief profile of its clinical use. (English)

1 reference

21 August 2017

0 references

3

1 reference

21 August 2017

1

Gin S Malhi

1 reference

21 August 2017

Danielle Adams

2

1 reference

21 August 2017

publication date

1 December 2009

1 reference

Australian and New Zealand Journal of Psychiatry

21 August 2017

published in

1 reference

21 August 2017

volume

43

1 reference

21 August 2017

issue

12

1 reference

21 August 2017

page(s)

1096-1104

1 reference

Lithium specificity in bipolar illness: a classic agent for the classic disorder

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

The treatment of manic psychoses by the administration of lithium salts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Lithium-carbonate treatment in depression and mania. A longitudinal double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Efficacy of lithium as acute treatment of manic-depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Does lithium treatment still work? Evidence of stable responses over three decades

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

A comparison of lithium carbonate and chlorpromazine in the treatment of excited schizo-affectives. Report of the Veterans Administration and National Institute of Mental Health collaborative study group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Electroconvulsive therapy in the treatment of mixed states in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Lithium - a continuing story in the treatment of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Clinical practice recommendations for bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Lithium Response in Unipolar Versus Bipolar Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Lithium in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Lithium carbonate response in depression. Prediction by unipolar/bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Bipolar depression: management options

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Initial lithium augmentation improves the antidepressant effects of standard TCA treatment in non-resistant depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Medicating mood with maintenance in mind: bipolar depression pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Lithium for maintenance treatment of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Rapid-cycling bipolar disorder: effects of long-term treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Pharmacologic treatment of rapid cycling and mixed states in bipolar disorder: an argument for the use of lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Controlled Studies of the Acute Antidepressant Effects of Lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Lithium treatment and prophylaxis in unipolar depression: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Are There Two Types of Unipolar Depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Clinical practice recommendations for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Efficacy and mechanisms of action of lithium augmentation in refractory major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Lithium augmentation therapy in refractory depression-update 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Current status of augmentation and combination treatments for major depressive disorder: a literature review and a proposal for a novel approach to improve practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Trials of Lithium, Chlorpromazine and Amitriptyline in Schizoaffective Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Factors associated with treatment success in lithium carbonate prophylaxis. Report of the Veterans Administration and National Institute of Mental Health collaborative study group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Lithium for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Lithium Treatment Reduces Suicide Risk in Recurrent Major Depressive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizoaffective illness

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Neuroprogression: pathways to progressive brain changes in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Meta-analysis, Database, and Meta-regression of 98 Structural Imaging Studies in Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

Long-term suicide risk of depression in the Lundby cohort 1947–1997 – severity and gender

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00048670903279937

10.3109/00048670903279937

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference